Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers TEACH Study

  • STATUS
    Recruiting
  • End date
    Mar 31, 2025
  • participants needed
    720
  • sponsor
    City of Hope Medical Center
Updated on 22 February 2021
cancer
skin cancer
allogeneic hematopoietic stem cell transplantation

Summary

This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.

Description

PRIMARY OBJECTIVES:

I. Determine the impact of patient activation and education (PAE, N=360) alone or with physician activation (PAE+Phys, N=360) on skin cancer screening and health promotion practices at 12 months, measured by percentage of survivors who conduct skin self-exam and receive physician skin exam, and time to detection and diagnosis of suspicious lesions.

II. Among primary care physicians of transplant patients, determine the impact of an e-learning teledermoscopy program compared with provision of print materials for identifying suspect lesions.

OUTLINE: Participants are randomized to 1 of 3 groups.

GROUP I: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months.

GROUP II: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit.

GROUP III: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. Physicians also receive a free dermatoscope with instructions for uploading images of suspect lesions and attend a 30-minute online course comprising additional descriptions of dermoscopic images for skin cancers and "mimickers" common in hematopoietic stem cell transplantation patients, along with clear instructions for using a dermatoscope and steps to integrate dermoscopy into their practice.

Details
Condition Skin Carcinoma, Non-melanoma Skin Cancer, Nonmelanoma Skin Cancer, carcinoma of the skin, carcinoma of skin
Treatment questionnaire administration, educational intervention, Text message, Computer-Assisted Intervention, Dermatoscope
Clinical Study IdentifierNCT04358276
SponsorCity of Hope Medical Center
Last Modified on22 February 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have Skin Carcinoma?
Do you have any of these conditions: Nonmelanoma Skin Cancer or carcinoma of skin or carcinoma of the skin or Skin Carcinoma or Non-melanoma Skin Cancer?
Do you have any of these conditions: Non-melanoma Skin Cancer or carcinoma of skin or Skin Carcinoma or carcinoma of the skin or Nonmelanoma Skin Cancer?
Do you have any of these conditions: Skin Carcinoma or carcinoma of the skin or Nonmelanoma Skin Cancer or carcinoma of skin or Non-melanoma Skin Cancer?
Do you have any of these conditions: Skin Carcinoma or carcinoma of skin or carcinoma of the skin or Non-melanoma Skin Cancer or Nonmelanoma Skin Cancer?
Do you have any of these conditions: Non-melanoma Skin Cancer or carcinoma of skin or Skin Carcinoma or Nonmelanoma Skin Cancer or carcinoma of the skin?
Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH)
Are 6 months (m) to 24 m (+/- 3 m) after HCT
Have seen a primary care provider (PCP) in the previous 12 m (expected > 95% of all eligible) or planning to do so in next 12 m
Have a mobile phone with the ability to receive text messages
Can fluently read and write in English or Spanish
Can understand and sign the study-specific Informed Consent Form (ICF)

Exclusion Criteria

Patients who have evidence of active hematologic malignancy or acute illness that would limit study participation
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note